USPP7636P - Mushroom plant named Brown Hybrid X618 - Google Patents
Mushroom plant named Brown Hybrid X618 Download PDFInfo
- Publication number
- USPP7636P USPP7636P US07/363,095 US36309589V US7636P US PP7636 P USPP7636 P US PP7636P US 36309589 V US36309589 V US 36309589V US 7636 P US7636 P US 7636P
- Authority
- US
- United States
- Prior art keywords
- mushroom
- verticillium
- disease
- varieties
- bubbles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 49
- 241000082085 Verticillium <Phyllachorales> Species 0.000 claims abstract description 24
- 108010044467 Isoenzymes Proteins 0.000 claims abstract description 7
- 201000010099 disease Diseases 0.000 claims description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 24
- 208000035240 Disease Resistance Diseases 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 13
- 241000222519 Agaricus bisporus Species 0.000 description 7
- VQKFNUFAXTZWDK-UHFFFAOYSA-N alpha-methylfuran Natural products CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 210000002816 gill Anatomy 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 1
- JMZRZEXRYJUHEB-UHFFFAOYSA-N 2-carbamothioylsulfanylethyl carbamodithioate;zinc Chemical compound [Zn].NC(=S)SCCSC(N)=S JMZRZEXRYJUHEB-UHFFFAOYSA-N 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 101100189913 Caenorhabditis elegans pept-1 gene Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000088076 Fungicola Species 0.000 description 1
- 241000346493 Lecanicillium fungicola Species 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- 241000383675 Trama Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000013435 necrotic lesion Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H15/00—Fungi; Lichens
Definitions
- Verticillium disease also called dry bubble and Verticillium spot
- fungus Verticillium fungicola Preuss
- Hassebr. var. fungicola as described by Gams and Zaaryen, Neth. J. Pl. Path. 88:57-58 (1982).
- Verticillium disease is controlled with hygienic cultural practices and/or fungicides.
- the most effective commercial fungicide approved and labeled for such control is zinc ethylene bisdithiocarbamate known to the trade as ZinebTM.
- ZinebTM zinc ethylene bisdithiocarbamate
- the Environmental Protection Administration has suspended its approval for the registration of this material, and it can no longer be used in the United States. Without it, many mushroom farms using conventional mushroom varieties will most likely not be able to sustain the yield and quality levels which they need to remain economically viable.
- the present invention is a new and distinct variety of mushroom characterized particularly by its greater resistance to Verticillium disease when compared to commercially available lines 56B and 381 and by its unique electrophoretic isozyme phenotype.
- This novel and distinct variety of mushroom is identified as Brown Hybrid X618.
- FIG. 1 illustrates the isozyme patterns used to characterize the claimed variety of mushroom identified as Brown Hybrid X618.
- FIG. 2 illustrates the disease severity protocol used to evaluate resistance of Brown Hybrid X618 and presently commercially available varieties of mushrooms to Verticillium disease.
- FIG. 3 illustrates the incidence of bubbles at various Verticillium disease infection levels of Brown Hybrid X618 as compared to commercially available line 56B.
- the bubbles referred are growth on mushroom beds of hypertrophied mushroom primordia, i.e., "bubbles", where normal mushrooms should have grown.
- FIG. 4 is a photograph showing two views of the X618 mushroom variety of the subject invention.
- homokaryons are roughly analogous to sperm and egg. They are derived from parent varieties and must be combined to produce a hybrid.
- Sylvan 381 is a commercially available, high-yielding white mushroom which is susceptible to Verticillium disease.
- Somycel 56B is a brown mushroom which is available from The Pennsylvania State University (PSU) Mushroom Culture Collection. It is used commercially, is low-yielding and somewhat resistant to Verticillium disease.
- the homokaryons (identified as 381-907 and 56B-4186) were typed by isozyme electrophoresis as taught by Royce and May in Mycologia, 74:93-102 (1982), the disclosure of which is incorporated herein by reference.
- the hybridization of X618 was achieved by dual culture of the homokaryons on agar by well-known methods.
- the genetic markers for these homokaryons, for the parent strains 381 and 56B and for X618 hybrid are set forth in Table 1. Table 1 indicates that X618 contains genetic material from each of the parent lines and is, therefore, a true hybrid of the parent varieties.
- FIG. 1 depicts the isozyme patterns of X618 which are referred to in Table 1.
- the X618 hybrid is genetically unique and its isozyme pattern is identifiable and distinct from that of any commercial or published variety.
- X618 is a tan to brown mushroom. The coloration is even to scrobiculate. Chroma meter readings of the mature pileus range on the CIE (Commission Internationale de l'Eclairage) scale from Yxy of 43.83, 0.3777, 0.3660, to a Yzy of 34.49, 0.3811, 0.3640, readings which correspond to The Royal Horticultural Society Colour Charts selections near 159A and 172D.
- the stipe is always bright white. Cap color tends to lighten later in the cropping cycle or when grown in absolute darkness. The tissue does not bruise or discolor upon injury.
- the cap margin is incurved. If the mushroom is permitted to become over-mature the cap margin becomes straight or flaring and the partial veil remains attached to the stipe.
- the pileus of X618 is 20-150 mm in diameter, planar to hemispherical and slightly umbillicate.
- the cuticle is smooth appressed fibrillose and not viscid.
- Gill trama are irregularly parallel and divergent at the tip. Gills are closely spaced and the basidia are clavate and mostly two-spored.
- Pleurocystidia are absent.
- Pileus tramal hyphae are 22-32 ⁇ m long and 11-14 ⁇ m wide.
- Pileus cutical hyphae are 10-12 ⁇ m in diameter and 23-27 ⁇ m in length.
- Spores are approximately 9 ⁇ m in length and 6 ⁇ m in diameter. They are ovate in shape and without a germ pore. Spore color is purple-brown to black.
- the X618 has a richer flavor than current white commercial mushroom varieties and is more firm and crunchy.
- the yield test results are summarized in Table 2.
- the yield characteristics of X618 are compared with a group of commercial mushroom varieties identified in Table 2 which were selected as representing the majority of the genetic variability which is presently available in commercial mushroom varieties.
- the class designation used is that described by Royce and May in Mycologia 74:93-102 (1982), the disclosure of which is incorporated herein by reference. Included in the comparisons are the parent strains of X618.
- the comparisons were made at three levels of Verticillium pathogen exposure (0, 100 and 1000 Verticillium spores added per pot). As measured in grams of mushrooms produced per test unit over a seven day period, Table 2 indicates that the yields of X618 compare favorably with the other varieties at the 0 exposure level and are better at the 100 and 1000 exposure levels than the preexisting varieties of mushrooms.
- Table 2 further displays the results of two tests for disease resistance.
- the tests measure the occurrences of certain characteristic symptoms of Verticillium disease. These symptoms are the (1) appearance of necrotic lesions on the cap and stem of the mushrooms and (2) growth on mushroom beds of "bubbles"--hypertrophied mushroom primordia--where normal mushrooms should be.
- the comparative measurements for the first test are called “disease severity ratings.” The ratings numbers correspond to proportions of total mushrooms in test crops which exhibit all symptoms.
- FIG. 2 describes the severity rating scale.
- the comparative measurement for the second test (indicated as "Bubbles") is the count of occurrences of the hypertrophied mushroom primordia in each production test unit at each pathogen exposure level. Both measures indicate that X618 has significantly higher resistance to Verticillium disease than do the comparison varieties of preexisting commercial varieties of mushrooms.
- Table 3 also displays the results of two tests for disease resistance. The results are similar to these which are reported in Table 2, except that X618 was compared only to its Somycel 56B parent, and it was compared at additional Verticillium disease exposure levels. As in the Table 2 test, both measures (bubbles and disease severity ratings) indicate that X618 has significantly higher resistance to Verticillium disease than its somewhat disease resistant parent.
- FIG. 3 displays the results of the bubbles measurement test reported in Table 3 in graphical form.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Environmental Sciences (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
A new and unique variety of brown mushroom is described. It exhibits (1) high production yields when compared to common commercial varieties, (2) excellent Verticillium disease resistance and (3) a distinct electrophoretic isozyme pattern.
Description
The present invention relates to a new and unique variety of mushroom plant of Agaricus bisporus (Lange) Imbach [=Agaricus brunnescens Peck].
Due to the endogenous automictic nuclear behavior of the cultivated mushroom as described by Kerrigan in Evolution and Agaricus bisporus, Ph.D. disseration (1989), University of California (Santa Barbara), few new and unique varieties of cultivated mushroom have become commercially available. Those that have become available and that have been used commercially were developed primarily to achieve high production yields and a bright, white color. As a result, nearly all commercially produced mushrooms are genetically very similar as described by Royce and May in Mycologia 74:93-102 (1982).
A consequence of the genetic similarity of most commercially-produced mushrooms is that they are susceptible to diseases caused by common pathogens. The diseases can have a devastating impact on the yield and quality of a mushroom harvest. Verticillium disease, also called dry bubble and Verticillium spot, is one of the most troublesome of these diseases. It is caused by the fungus Verticillium fungicola (Preuss) Hassebr. var. fungicola as described by Gams and Zaaryen, Neth. J. Pl. Path. 88:57-58 (1982).
Typically, Verticillium disease is controlled with hygienic cultural practices and/or fungicides. Currently, the most effective commercial fungicide approved and labeled for such control is zinc ethylene bisdithiocarbamate known to the trade as Zineb™. However, the Environmental Protection Administration has suspended its approval for the registration of this material, and it can no longer be used in the United States. Without it, many mushroom farms using conventional mushroom varieties will most likely not be able to sustain the yield and quality levels which they need to remain economically viable.
Consequently, the incorporation of disease resistance into the genetic makeup of mushroom varieties represents an efficient, cost-effective and environmentally responsible solution to the problem, and a need for such a disease resistant mushroom exists.
The present invention is a new and distinct variety of mushroom characterized particularly by its greater resistance to Verticillium disease when compared to commercially available lines 56B and 381 and by its unique electrophoretic isozyme phenotype. This novel and distinct variety of mushroom is identified as Brown Hybrid X618.
FIG. 1 illustrates the isozyme patterns used to characterize the claimed variety of mushroom identified as Brown Hybrid X618.
FIG. 2 illustrates the disease severity protocol used to evaluate resistance of Brown Hybrid X618 and presently commercially available varieties of mushrooms to Verticillium disease.
FIG. 3 illustrates the incidence of bubbles at various Verticillium disease infection levels of Brown Hybrid X618 as compared to commercially available line 56B. The bubbles referred are growth on mushroom beds of hypertrophied mushroom primordia, i.e., "bubbles", where normal mushrooms should have grown.
FIG. 4 is a photograph showing two views of the X618 mushroom variety of the subject invention.
The present invention is a new and distinct variety of the commonly cultivated white mushroom Agaricus bisporus (Lange) Imbach [=Agaricus brunnescens Peck]. It is referred to by the variety name of X618 and was produced in the breeding program of Sylvan Spawn Laboratory, Inc., Kittanning, Pa.
In mushroom breeding, compatible breeding lines, called homokaryons, are roughly analogous to sperm and egg. They are derived from parent varieties and must be combined to produce a hybrid.
The X618 variety resulted from the hybridization of two compatible homokaryons. The varieties from which these homokaryons were derived are called the parent varieties. These are Sylvan 381 and Somycel 56B. Sylvan 381 is a commercially available, high-yielding white mushroom which is susceptible to Verticillium disease. Somycel 56B is a brown mushroom which is available from The Pennsylvania State University (PSU) Mushroom Culture Collection. It is used commercially, is low-yielding and somewhat resistant to Verticillium disease.
The homokaryons (identified as 381-907 and 56B-4186) were typed by isozyme electrophoresis as taught by Royce and May in Mycologia, 74:93-102 (1982), the disclosure of which is incorporated herein by reference. The hybridization of X618 was achieved by dual culture of the homokaryons on agar by well-known methods. The genetic markers for these homokaryons, for the parent strains 381 and 56B and for X618 hybrid are set forth in Table 1. Table 1 indicates that X618 contains genetic material from each of the parent lines and is, therefore, a true hybrid of the parent varieties. FIG. 1 depicts the isozyme patterns of X618 which are referred to in Table 1. The X618 hybrid is genetically unique and its isozyme pattern is identifiable and distinct from that of any commercial or published variety.
X618 is a tan to brown mushroom. The coloration is even to scrobiculate. Chroma meter readings of the mature pileus range on the CIE (Commission Internationale de l'Eclairage) scale from Yxy of 43.83, 0.3777, 0.3660, to a Yzy of 34.49, 0.3811, 0.3640, readings which correspond to The Royal Horticultural Society Colour Charts selections near 159A and 172D. The stipe is always bright white. Cap color tends to lighten later in the cropping cycle or when grown in absolute darkness. The tissue does not bruise or discolor upon injury. The cap margin is incurved. If the mushroom is permitted to become over-mature the cap margin becomes straight or flaring and the partial veil remains attached to the stipe.
The pileus of X618 is 20-150 mm in diameter, planar to hemispherical and slightly umbillicate. The cuticle is smooth appressed fibrillose and not viscid. Gill trama are irregularly parallel and divergent at the tip. Gills are closely spaced and the basidia are clavate and mostly two-spored. Pleurocystidia are absent. Pileus tramal hyphae are 22-32 μm long and 11-14 μm wide. Pileus cutical hyphae are 10-12 μm in diameter and 23-27 μm in length. Spores are approximately 9 μm in length and 6 μm in diameter. They are ovate in shape and without a germ pore. Spore color is purple-brown to black.
The X618 has a richer flavor than current white commercial mushroom varieties and is more firm and crunchy.
Evaluations of X618 were conducted to assess its production yield potential and its resistance to Verticillium. Small scale production tests were performed in Sylvan Spawn Laboratory, Inc.'s mushroom cultivation facilities at Cabot, Pa. Larger scale tests were performed in the facilities of Moonlight Mushrooms, Inc. at Worthington, Pa.
After the new variety was established, it was reproduced and maintained asexually by standard techniques in the Sylvan Spawn Laboratories facilities at Cabot and Kittanning, Pa. using standard agar and grain media.
The yield test results are summarized in Table 2. The yield characteristics of X618 are compared with a group of commercial mushroom varieties identified in Table 2 which were selected as representing the majority of the genetic variability which is presently available in commercial mushroom varieties. The class designation used is that described by Royce and May in Mycologia 74:93-102 (1982), the disclosure of which is incorporated herein by reference. Included in the comparisons are the parent strains of X618. The comparisons were made at three levels of Verticillium pathogen exposure (0, 100 and 1000 Verticillium spores added per pot). As measured in grams of mushrooms produced per test unit over a seven day period, Table 2 indicates that the yields of X618 compare favorably with the other varieties at the 0 exposure level and are better at the 100 and 1000 exposure levels than the preexisting varieties of mushrooms.
Table 2 further displays the results of two tests for disease resistance. The tests measure the occurrences of certain characteristic symptoms of Verticillium disease. These symptoms are the (1) appearance of necrotic lesions on the cap and stem of the mushrooms and (2) growth on mushroom beds of "bubbles"--hypertrophied mushroom primordia--where normal mushrooms should be. The comparative measurements for the first test (indicated as "Disease") are called "disease severity ratings." The ratings numbers correspond to proportions of total mushrooms in test crops which exhibit all symptoms. FIG. 2 describes the severity rating scale. The comparative measurement for the second test (indicated as "Bubbles") is the count of occurrences of the hypertrophied mushroom primordia in each production test unit at each pathogen exposure level. Both measures indicate that X618 has significantly higher resistance to Verticillium disease than do the comparison varieties of preexisting commercial varieties of mushrooms.
Table 3 also displays the results of two tests for disease resistance. The results are similar to these which are reported in Table 2, except that X618 was compared only to its Somycel 56B parent, and it was compared at additional Verticillium disease exposure levels. As in the Table 2 test, both measures (bubbles and disease severity ratings) indicate that X618 has significantly higher resistance to Verticillium disease than its somewhat disease resistant parent. FIG. 3 displays the results of the bubbles measurement test reported in Table 3 in graphical form.
TABLE 1 ______________________________________ Phenotypes of Alleles Found In X618, Its Parent Homokaryons and Its Parent Varieties BIOCHEMICAL LOCI Variety AAT ADH EST GPT Pep-2 PGM ______________________________________ 381 100/ 100/149 100/ 100/100 100/111 100/181 100 10056B 81/ 149/149 82/ 100/133 100/111 100/181 100 82 381-907 100 149 100 100 111 100 56B-4186 81 149 82 133 111 181X618 81/ 149/149 82/ 100/133 111/111 100/181 100 100 ______________________________________
TABLE 2 ______________________________________ Mushroom Yields in Grams, Disease Severity Ratings and Incidence of Bubbles For Various Mushroom Varieties At Various Disease Infection Levels ______________________________________ VARIETIES X618 S100 S110 Variety Hybrid Hybrid Hybrid Mc310 Mc266 Type Brown Off White Off White White White Class None 11 11 2 22 From Sylvan Sylvan Sylvan PSU PSU ______________________________________ 0 Verticillium spores added per pot Yield 277 295 163 132 313Severity 0 0 0 0 0Rating Bubbles 0 1 0 0 0 100 Verticillium spores added per pot Yield 363 236 158 86 181Severity 1 3 3 3 4Rating Bubbles 0 3 50+ 33 47 1000 Verticillium spores added per pot Yield 336 66 227 54 299Severity 2 5 5 5 5Rating Bubbles 7 50+ 50+ 50 98 ______________________________________ VARIETIES S8132 S671 S381 Variety Off Golden 56B Hybrid Type White White Brown White Class 31 19 27 11 From Sylvan Sylvan Somycel Sylvan ______________________________________ 0 Verticillium spores adder per pot Yield 168 227 127 267Severity 0 0 0 0Rating Bubbles 0 0 0 0 100 Verticillium spores added per pot Yield 217 145 136 349Severity 3 3 3 4 Rating Bubbles 77+ 65 32 30 1000 Verticillium spores added per pot Yield 190 77 136 308Severity 5 5 4 5 Rating Bubbles 132 76 35 50+ ______________________________________
TABLE 3 ______________________________________ Incidence of Bubbles For Variety 56B and X618 At Various Disease Infection Levels VARIETY Number of 56B X618 Verticillium Severity Severity Spores Bubbles Rating Bubbles Rating ______________________________________ 0 0 0 0 0 100 37 4 0 0 500 41 4 0 2 1000 50 4 4 3 4000 96 5 7 3 ______________________________________
Claims (1)
1. A new and distinct variety of mushroom substantially as shown and described, characterized particularly as to novelty by its greater resistance to Verticillium disease when compared to commercially available lines 56B and 381 and by its unique electrophoretic isozyme phenotype.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/363,095 USPP7636P (en) | 1989-06-08 | 1989-06-08 | Mushroom plant named Brown Hybrid X618 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/363,095 USPP7636P (en) | 1989-06-08 | 1989-06-08 | Mushroom plant named Brown Hybrid X618 |
Publications (1)
Publication Number | Publication Date |
---|---|
USPP7636P true USPP7636P (en) | 1991-08-27 |
Family
ID=23428778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/363,095 Expired - Lifetime USPP7636P (en) | 1989-06-08 | 1989-06-08 | Mushroom plant named Brown Hybrid X618 |
Country Status (1)
Country | Link |
---|---|
US (1) | USPP7636P (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5304721A (en) * | 1992-06-18 | 1994-04-19 | Sylvan Spawn Laboratory Incorporated | Method for the production of high proportions of homokaryons in breeding stock of the mushroom Agaricus bisporus |
WO1998021975A1 (en) | 1995-02-09 | 1998-05-28 | Amycel, Inc. | Mushroom caps with reduced scaling |
US20070033679A1 (en) * | 2005-08-04 | 2007-02-08 | Amycel, Inc. | Brown mushrooms for commercial production |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4608775A (en) * | 1983-07-29 | 1986-09-02 | National Research Development Corporation | Mushroom mutant strains |
-
1989
- 1989-06-08 US US07/363,095 patent/USPP7636P/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4608775A (en) * | 1983-07-29 | 1986-09-02 | National Research Development Corporation | Mushroom mutant strains |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5304721A (en) * | 1992-06-18 | 1994-04-19 | Sylvan Spawn Laboratory Incorporated | Method for the production of high proportions of homokaryons in breeding stock of the mushroom Agaricus bisporus |
US5684228A (en) * | 1992-06-18 | 1997-11-04 | Sylvan Spawn Laboratory Incorporated | Method for the production of high proportions of homokaryons in breeding stock of the mushroom agaricus bisporus |
WO1998021975A1 (en) | 1995-02-09 | 1998-05-28 | Amycel, Inc. | Mushroom caps with reduced scaling |
US20070033679A1 (en) * | 2005-08-04 | 2007-02-08 | Amycel, Inc. | Brown mushrooms for commercial production |
WO2007019306A3 (en) * | 2005-08-04 | 2009-04-30 | Amycel Inc | Brown mushrooms for commercial production |
US7608760B2 (en) * | 2005-08-04 | 2009-10-27 | Amycel Inc. | Brown mushrooms for commercial production |
US20100212042A1 (en) * | 2005-08-04 | 2010-08-19 | Amycel, Inc. | Strain of Brown Mushrooms for Commercial Production |
AU2006278465B2 (en) * | 2005-08-04 | 2011-06-02 | Amycel, Inc. | Brown mushrooms for commercial production |
EP1993350B1 (en) | 2005-08-04 | 2016-06-29 | Amycel, Inc. | Brown mushrooms for commercial production |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USPP31827P2 (en) | Strawberry plant variety named ‘DrisStrawSeventySix’ | |
USPP26312P2 (en) | Blueberry plant named ‘FL06-203’ | |
USPP7636P (en) | Mushroom plant named Brown Hybrid X618 | |
USPP27771P2 (en) | Blueberry plant named ‘FL06-556’ | |
US7968769B2 (en) | Alfalfa variety named magnum VI | |
Pooler | Crapemyrtle | |
Deng et al. | Independent inheritance of leaf shape and main vein color in caladium | |
USPP32461P2 (en) | Corylus plant named ‘Hunterdon’ | |
USPP32494P2 (en) | Corylus plant named ‘Somerset’ | |
EP1973397B1 (en) | Novel cucurbita plants | |
Tetali et al. | Grape Breeding for powdery mildew resistance | |
US20040055033A1 (en) | Multiple disease resistant cucumber inbred line | |
USPP33802P3 (en) | Blueberry plant named ‘Colossus’ | |
USPP35896P2 (en) | Blueberry plant named ‘FL17-141’ | |
USPP13931P2 (en) | Blueberry plant called ‘Southern Belle’ | |
USPP32182P3 (en) | Blueberry plant named ‘WAYNE’ | |
USPP33896P2 (en) | Blueberry plant named ‘Sentinel’ | |
USPP35895P3 (en) | Blueberry plant named ‘FL11-51’ | |
USPP35886P2 (en) | Cordyline plant named ‘TUS020’ | |
USPP34011P2 (en) | Quercus tree named ‘QRMTF’ | |
USPP32460P2 (en) | Corylus plant named ‘Raritan’ | |
USPP19257P3 (en) | Corokia plant named ‘Phantom’ | |
US20230103285P1 (en) | Maitake mushroom named 'yukigunimai 14go' | |
Kosinski et al. | Thuja× soeegaardii (Cupressaceae)–a new name for an old hybrid | |
USPP30914P3 (en) | Vaccinium plant named ‘RYOKU NH-13’ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SYLVAN SPAWN LABORATORY, INC., WEST HILLS INDUSTRI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:SPEAR, MARK C.;MILLER, REBECCA;REEL/FRAME:005088/0437 Effective date: 19890606 |